Marshall Wace’s NextGen Healthcare, Inc. Common Stock NXGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-43,000
| Closed | -$1.02M | – | 2748 |
|
|
2023
Q3 | $1.02M | Sell |
43,000
-116,299
| -73% | -$2.19M | ﹤0.01% | 1500 |
|
|
2023
Q2 | $2.58M | Buy |
159,299
+127,196
| +396% | +$2.11M | 0.01% | 1285 |
|
|
2023
Q1 | $559K | Buy |
+32,103
| New | +$577K | ﹤0.01% | 2056 |
|
|
2020
Q3 | – | Sell |
-93,870
| Closed | -$1.03M | – | 2013 |
|
|
2020
Q2 | $1.03M | Sell |
93,870
-17,712
| -16% | -$184K | 0.01% | 986 |
|
|
2020
Q1 | $1.17M | Buy |
111,582
+74,448
| +200% | +$960K | 0.01% | 767 |
|
|
2019
Q4 | $597K | Sell |
37,134
-281,608
| -88% | -$4.65M | ﹤0.01% | 1117 |
|
|
2019
Q3 | $5M | Sell |
318,742
-124,926
| -28% | -$2.08M | 0.04% | 505 |
|
|
2019
Q2 | $8.83M | Buy |
443,668
+277,463
| +167% | +$5.18M | 0.07% | 318 |
|
|
2019
Q1 | $2.8M | Buy |
166,205
+91,967
| +124% | +$1.59M | 0.03% | 647 |
|
|
2018
Q4 | $1.12M | Buy |
+74,238
| New | +$1.27M | 0.01% | 884 |
|
|
2016
Q4 | – | Sell |
-43,696
| Closed | -$494K | – | 1156 |
|
|
2016
Q3 | $494K | Buy |
+43,696
| New | +$525K | ﹤0.01% | 802 |
|
|
2016
Q1 | – | Sell |
-11,843
| Closed | -$191K | – | 1223 |
|
|
2015
Q4 | $191K | Buy |
+11,843
| New | +$173K | ﹤0.01% | 921 |
|
|
2015
Q3 | – | Sell |
-14,867
| Closed | -$246K | – | 1093 |
|
|
2015
Q2 | $246K | Buy |
+14,867
| New | +$240K | ﹤0.01% | 796 |
|
|
2014
Q4 | – | Sell |
-80,718
| Closed | -$1.11M | – | 1019 |
|
|
2014
Q3 | $1.11M | Buy |
+80,718
| New | +$1.22M | 0.02% | 539 |
|
Other funds holding NXGN
Marshall Wace's NXGN Position: Q4 2023 in Review
Marshall Wace sold out of NextGen Healthcare, Inc. Common Stock (NXGN) in Q4 2023, closing a stake of 43,000 shares — an estimated $1.02M sold.
Marshall Wace first reported a position in NXGN in Q3 2014 and held it in 14 quarters. The position peaked at $8.83M in Q2 2019. 1 fund tracked by Wall St. Rank holds NXGN as of Q4 2023.
- Marshall Wace reported no remaining NextGen Healthcare, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
- Marshall Wace sold 43,000 NextGen Healthcare, Inc. Common Stock shares in Q4 2023, an estimated $1.02M.
- Marshall Wace first reported a position in NextGen Healthcare, Inc. Common Stock in Q3 2014 and held it in 14 quarters.
- Marshall Wace's NextGen Healthcare, Inc. Common Stock position peaked at $8.83M in Q2 2019.
- 1 fund tracked by Wall St. Rank held NextGen Healthcare, Inc. Common Stock as of Q4 2023.
Based on Marshall Wace's 13F filing for Q4 2023, filed 14 Feb 2024.